Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 6, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	36	53	77	130	61	92
Market Cap Growth	-51.95%	-30.35%	-40.82%	111.36%	-33.26%	-66.44%
Enterprise Value	30.33	47.26	51.98	112.54	27.69	71.28
Last Close Price	0.39	0.64	0.98	1.86	0.88	1.65
PB Ratio	14.69	21.51	4.01	24.95	2.08	4.41
P/TBV Ratio	13.15	21.87	3.95	25.23	1.94	4.31
Debt / Equity Ratio	0.02	0.02	0.01	0	0	0
Net Debt / Equity Ratio	-2.47	-2.47	-1.29	-3.27	-1.14	-0.99
Net Debt / EBITDA Ratio	0.27	0.27	1.21	0.91	2.06	0.92
Net Debt / FCF Ratio	0.34	0.34	1.49	1.04	2.65	0.87
Quick Ratio	1.39	1.39	6.21	6.34	9.07	8.33
Current Ratio	1.52	1.52	6.35	6.66	9.57	8.92
Return on Equity (ROE)	-712.61%	-287.13%	-272.58%	-16.35%	-99.35%	-76.21%
Return on Assets (ROA)	-208.35%	-121.71%	-85.89%	-67.20%	-54.43%	-68.40%
Return on Invested Capital (ROIC)	-10725.80%	-9704.33%	-12874.40%	-31650.80%	-9032.13%	-10285.10%
Return on Capital Employed (ROCE)	-399.20%	-166.45%	-101.48%	-76.35%	-60.97%	-76.21%
Buyback Yield / Dilution	-8.51%	-8.51%	-10.10%	-7.57%	-19.25%	-9.31%
Total Shareholder Return	-8.51%	-8.51%	-10.10%	-7.57%	-19.25%	-9.31%